Cardlytics Inc (NASDAQ:CDLX) insider Kirk Somers sold 2,595 shares of the business’s stock in a transaction that occurred on Tuesday, March 26th. The shares were sold at an average price of $15.65, for a total value of $40,611.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Kirk Somers also recently made the following trade(s):

  • On Thursday, March 21st, Kirk Somers sold 2,591 shares of Cardlytics stock. The shares were sold at an average price of $15.67, for a total value of $40,600.97.

Shares of CDLX stock opened at $15.99 on Thursday. Cardlytics Inc has a 1-year low of $9.80 and a 1-year high of $28.29. The firm has a market cap of $320.17 million and a P/E ratio of -7.47. The company has a current ratio of 2.40, a quick ratio of 2.40 and a debt-to-equity ratio of 0.90.

Cardlytics (NASDAQ:CDLX) last announced its quarterly earnings data on Tuesday, March 5th. The company reported ($0.06) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.43) by $0.37. Cardlytics had a negative return on equity of 92.07% and a negative net margin of 35.20%. Equities analysts predict that Cardlytics Inc will post -1.88 EPS for the current fiscal year.

A number of hedge funds have recently made changes to their positions in the stock. FMR LLC grew its holdings in Cardlytics by 0.5% during the fourth quarter. FMR LLC now owns 3,211,725 shares of the company’s stock worth $34,783,000 after acquiring an additional 17,153 shares during the period. Canaan Partners VIII LLC acquired a new position in Cardlytics during the fourth quarter worth $25,647,000. Frontier Capital Management Co. LLC grew its holdings in Cardlytics by 105.6% during the fourth quarter. Frontier Capital Management Co. LLC now owns 1,462,777 shares of the company’s stock worth $15,842,000 after acquiring an additional 751,148 shares during the period. Jennison Associates LLC grew its holdings in Cardlytics by 58.3% during the fourth quarter. Jennison Associates LLC now owns 1,264,354 shares of the company’s stock worth $13,693,000 after acquiring an additional 465,855 shares during the period. Finally, Cannell Capital LLC acquired a new position in Cardlytics during the fourth quarter worth $5,491,000. 80.89% of the stock is currently owned by hedge funds and other institutional investors.

CDLX has been the topic of a number of recent research reports. Zacks Investment Research lowered Cardlytics from a “buy” rating to a “hold” rating in a report on Thursday, January 3rd. Bank of America raised Cardlytics from a “neutral” rating to a “buy” rating and set a $15.00 target price on the stock in a report on Tuesday, January 15th. Finally, SunTrust Banks reaffirmed a “buy” rating and set a $25.00 price objective on shares of Cardlytics in a report on Wednesday, March 6th. One analyst has rated the stock with a sell rating and seven have issued a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $22.86.

WARNING: “Kirk Somers Sells 2,595 Shares of Cardlytics Inc (CDLX) Stock” was first reported by Watch List News and is the property of of Watch List News. If you are accessing this piece on another site, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The original version of this piece can be read at https://www.watchlistnews.com/kirk-somers-sells-2595-shares-of-cardlytics-inc-cdlx-stock/2923337.html.

Cardlytics Company Profile

Cardlytics, Inc operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels.

Recommended Story: Price to Earnings Ratio (PE), For Valuing Stocks

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.